Structural modification of receptor-binding technetium-99m complexes in order to improve brain uptake

被引:33
作者
Johannsen, B
Berger, R
Brust, P
Pietzsch, HJ
Scheunemann, M
Seifert, S
Spies, H
Syhre, R
机构
[1] Inst. F. Bioanorg. Radpharm. Chem., Forschungszentrum Rossendorf e.
关键词
blood-brain barrier; brain uptake; serotonin receptor binding; technetium-99m complexes; pK(3) values; lipophilicity;
D O I
10.1007/BF01728770
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Low brain uptake is a generally accepted problem in developing technetium-99m brain receptor imaging agents. For a class of potential 5-HT2A receptor-binding agents we tried to improve the original low brain uptake of 0.4% injected dose (ID) in rats 5 min p.i. by modifying the lipophilic properties of the molecules. Because of the presence of a protonable nitrogen. which according to the pK(a) value leads to ionization of the molecule at blood pH, the pK(a) value was considered to be the parameter most suitable for adjustment of lipophilicity. Insertion of ether-oxygen in the molecule of five candidates lowers the apparent pK(a) value from 10.0 to 8.3 and dramatically increases the brain uptake to 1.3% ID at 5 min, The direct relationship between brain uptake and apparent pK(a) cannot be simply explained by the increase in the pK(a)-governed proportion of the neutral species.
引用
收藏
页码:316 / 319
页数:4
相关论文
共 16 条
  • [1] BAIDOO KE, 1995, J NUCL MED, V36, pP28
  • [2] SYNTHESIS AND IN-VIVO EVALUATION OF A TC-99M/99-DADT-BENZOVESAMICOL - A POTENTIAL MARKER FOR CHOLINERGIC NEURONS
    DELROSARIO, RB
    JUNG, YW
    BAIDOO, KE
    LEVER, SZ
    WIELAND, DM
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (02): : 197 - 203
  • [3] RADIOLABELING WITH TC-99M TO STUDY HIGH-CAPACITY AND LOW-CAPACITY BIOCHEMICAL SYSTEMS
    ECKELMAN, WC
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1995, 22 (03): : 249 - 263
  • [4] Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: Structure-affinity considerations
    Johannsen, B
    Scheunemann, M
    Spies, H
    Brust, P
    Wober, J
    Syhre, R
    Pietzsch, HJ
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (04): : 429 - 438
  • [5] JOHANNSEN B, 1995, J NUCL MED, V36, pP27
  • [6] NOVEL TECHNETIUM LIGANDS WITH AFFINITY FOR THE MUSCARINIC CHOLINERGIC RECEPTOR
    LEVER, SZ
    BAIDOO, KE
    MAHMOOD, A
    MATSUMURA, K
    SCHEFFEL, U
    WAGNER, HN
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (02): : 157 - 164
  • [7] Madras BK, 1996, SYNAPSE, V22, P239, DOI 10.1002/(SICI)1098-2396(199603)22:3<239::AID-SYN6>3.0.CO
  • [8] 2-D
  • [9] MEGALLA S, 1995, J AM CHEM SOC, V117, P11037
  • [10] NOWOTNIK DP, 1992, RADIOPHARMACEUTICALS, P37